Nurse Practitioner in Grand Bay, AL Accepting Medicare
4 Nurse Practitioner nurses found. Showing 1 - 4
 Deanna Walker Seaman, NP Nurse Practitioner - Pediatrics Medicare: Medicare Enrolled Practice Location: 10075 Grand Bay Wilmer Rd S, Grand Bay, AL 36541 Phone: 251-865-1852 Fax: 251-865-1859 |
Mrs. Emily Williams Venatta, FNP-C, AGACNP-BC Nurse Practitioner - Acute Care Medicare: Accepting Medicare Assignments Practice Location: 6270 Gaston Loop Rd W, Grand Bay, AL 36541 Phone: 205-299-2955 |
 Mr. Lloyd Sean Stokes, NP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 10075 Grand Bay Wilmer Rd S, Grand Bay, AL 36541 Phone: 251-865-1852 |
Mr. Justin Blake Stokes, CRNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 10075 Grand Bay Wilmer Rd S, Grand Bay, AL 36541 Phone: 518-651-8522 Fax: 251-865-1854 |
News Archive
Study offers new clues for early autism diagnosis
A new study shows significant differences in brain development in high-risk infants who develop autism starting as early as age 6 months. The findings published in the American Journal of Psychiatry reveal that this abnormal brain development may be detected before the appearance of autism symptoms in an infant's first year of life. Autism is typically diagnosed around the age of 2 or 3.
GSA selects Penn professor as 2012 recipient of Maxwell A. Pollack Award for Productive Aging
The Gerontological Society of America (GSA) - the nation's largest interdisciplinary organization devoted to the field of aging - has chosen Mary Naylor, PhD, RN, FAAN, of the University of Pennsylvania as the 2012 recipient of the Maxwell A. Pollack Award for Productive Aging.
New review examines potential of antioxidant therapies to combat neurodegenerative disorders
A new review examines the potential of antioxidant approaches for the treatment of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis.
Intranasal COVID-19 vaccine developed from bacterial extracellular vesicle induces robust antibody response in preclinical trials
A team of US-based scientists recently developed a novel vaccine candidate against SARS-CoV-2, the causative pathogen of COVID-19. The vaccine is composed of extracellular vesicles of Salmonella typhimurium incorporated with the spike receptor-binding domain (RBD) of SARS-CoV-2. Upon intranasal administration in hamsters, the vaccine induces strong blood antibody titers and protects against severe COVID-19.
ZIOPHARM receives Notice of Allowance for palifosfamide from U.S. patent office
ZIOPHARM Oncology, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for Application Serial No. 11/257,766 entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to compounds, pharmaceutical compositions, and lyophilisates. These claims cover the Company's proprietary palifosfamide composition (ZIO-201 or ZymafosTM). The Company has recently reported positive randomized Phase II sarcoma interim data for intravenous palifosfamide at the Annual Meeting of the Connective Tissue Oncology Society (CTOS) on November 6, 2009 and expects, following U.S. Food and Drug Administration (FDA) review, to initiate a registration trial the first half of 2010.
› Verified 8 days ago